See more : Yellow Pages Limited (YLWDF) Income Statement Analysis – Financial Results
Complete financial analysis of Brighter AB (publ) (BRIG.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Brighter AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- Bombay Oxygen Investments Limited (BOMOXY-B1.BO) Income Statement Analysis – Financial Results
- Lincoln National Corporation (LNC-PD) Income Statement Analysis – Financial Results
- PyroGenesis Canada Inc. (PYR.TO) Income Statement Analysis – Financial Results
- ALPHALOGIC INDUSTRIES LIMITED (ALPHAIND.BO) Income Statement Analysis – Financial Results
- Trelleborg AB (publ) (TBABF) Income Statement Analysis – Financial Results
Brighter AB (publ) (BRIG.ST)
About Brighter AB (publ)
Brighter AB (publ), a health-tech company, develops solutions for the treatment of chronic condition in Sweden and internationally. It is developing Actiste, a daily diabetes care of insulin-treated diabetes; Actiste Mini for the treatment of non-insulin-treated diabetes; and Nectarine Health, an AI-based monitoring solution. The company offers its products to patients and their relatives, healthcare providers, authorities and governments, insurance companies and employers, pharmaceutical industry, clinical research organizations, and academic organizations. Brighter AB (publ) was founded in 2007 and is based in Kista, Sweden.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.27M | 12.29M | 2.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | -33.73M | -56.77M | -33.32M | -25.02M | -29.75M | -21.70M | -15.60M | -1.75M | -883.74K | 0.00 | 0.00 | 2.73K | 0.00 | 0.00 |
| Gross Profit | 35.00M | 69.06M | 35.72M | 25.02M | 29.75M | 21.70M | 15.60M | 1.75M | 883.74K | 0.00 | 0.00 | -2.73K | 0.00 | 0.00 |
| Gross Profit Ratio | 2,764.45% | 562.07% | 1,489.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 106.55M | 144.65M | 78.41M | 56.66M | 43.38M | 29.88M | 21.17M | 3.47M | 906.79K | 896.91K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 106.55M | 144.65M | 78.41M | 56.66M | 43.38M | 29.88M | 21.17M | 3.47M | 906.79K | 896.91K | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 113.53M | 140.85M | 28.02M | 12.47M | 6.70M | 6.43M | 5.04M | 6.32M | 2.33M | 1.51M | 674.77K | 343.48K | 170.42M | 72.55M |
| Operating Expenses | 220.08M | 285.50M | 106.43M | 69.13M | 50.08M | 36.31M | 26.21M | 9.79M | 3.24M | 2.41M | 674.77K | 343.48K | 170.42M | 72.55M |
| Cost & Expenses | 186.35M | 228.73M | 73.12M | 44.11M | 20.33M | 14.61M | 10.61M | 8.04M | 2.35M | 2.41M | 674.77K | 346.21K | 170.42M | 72.55M |
| Interest Income | 1.70M | 4.06M | 1.00M | 1.52M | 40.00K | 2.69K | 11.70K | 134.49K | 1.95K | 14.57K | 3.91K | 286.00 | 0.00 | 0.00 |
| Interest Expense | 5.94M | 2.34M | 6.99M | 4.80M | 1.69M | 124.51K | 62.65K | 141.05K | 428.51K | 151.02K | 87.67K | 35.85K | 0.00 | 0.00 |
| Depreciation & Amortization | 51.81M | 67.48M | 5.11M | 163.00K | 202.00K | 191.71K | 94.15K | 1.23M | 1.13M | 548.82K | 261.62K | 153.09K | 105.44M | -49.12M |
| EBITDA | -152.69M | -174.34M | -77.58M | -48.12M | -25.40M | -14.41M | -11.31M | -21.07M | -1.22M | -1.85M | -409.24K | -192.84K | -77.38M | -121.67M |
| EBITDA Ratio | -12,061.14% | -1,418.98% | -3,235.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -204.50M | -216.44M | -70.72M | -44.11M | -20.33M | -14.61M | -10.61M | -8.04M | -2.35M | -2.41M | -674.77K | -346.21K | -170.42M | -72.55M |
| Operating Income Ratio | -16,153.32% | -1,761.70% | -2,949.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -5.38M | -27.71M | -18.97M | -8.97M | -6.97M | -121.82K | -859.45K | -14.40M | -426.56K | -136.45K | -83.75K | -35.57K | -12.39M | -49.12M |
| Income Before Tax | -209.88M | -244.15M | -89.69M | -53.08M | -27.29M | -14.73M | -11.47M | -22.44M | -2.78M | -2.55M | -758.52K | -381.78K | -182.81M | -121.67M |
| Income Before Tax Ratio | -16,578.20% | -1,987.24% | -3,739.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 5.94M | -25.37M | -11.98M | -4.18M | -5.28M | 2.69K | -796.80K | -14.26M | 1.95K | 14.57K | 3.91K | 286.00 | -12.39M | 0.00 |
| Net Income | -215.82M | -244.15M | -89.69M | -53.08M | -27.29M | -14.73M | -11.47M | -22.44M | -2.78M | -2.55M | -758.52K | -381.78K | -182.81M | -121.67M |
| Net Income Ratio | -17,047.47% | -1,987.24% | -3,739.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.42 | -1.10 | -0.98 | -0.43 | -0.27 | -0.16 | -0.17 | -0.76 | -0.13 | -0.13 | -0.04 | -0.02 | -9.01 | -5.99 |
| EPS Diluted | -0.42 | -1.10 | -0.98 | -0.43 | -0.27 | -0.16 | -0.17 | -0.67 | -0.13 | -0.13 | -0.04 | -0.02 | -9.01 | -5.99 |
| Weighted Avg Shares Out | 512.78M | 221.41M | 91.33M | 124.41M | 102.45M | 93.94M | 67.85M | 29.46M | 21.49M | 20.29M | 20.29M | 20.29M | 20.29M | 20.29M |
| Weighted Avg Shares Out (Dil) | 512.78M | 221.41M | 91.33M | 124.41M | 102.45M | 93.94M | 67.85M | 33.64M | 21.49M | 20.29M | 20.29M | 20.29M | 20.29M | 20.29M |
Source: https://incomestatements.info
Category: Stock Reports